| Literature DB >> 30625312 |
Guang Yang1, Changyang Zhou2, Ran Wang3, Shisheng Huang4, Yu Wei2, Xianfa Yang1, Yajing Liu4, Jianan Li4, Zongyang Lu4, Wenqin Ying2, Xiajun Li4, Naihe Jing1, Xingxu Huang5, Hui Yang6, Yunbo Qiao7.
Abstract
The coactivator-associated arginine methyltransferase CARM1 catalyzes the methylation of histone H3 arginine 17/26 (H3R17/26me) and non-histone proteins at arginine residues to regulate gene transactivation through profiling or Carm1 overexpression assays. However, the direct relationship between H3R17/26me and its causal role in mouse embryo development remains largely unclear. Here, we use rAPOBEC1-XTEN-Cas9n-UGI (BE3) to efficiently introduce a point mutation (R17H) at multiple Hist1/2H3 loci and a premature-stop codon into the catalytic domain of CARM1 in mouse embryos, resulting in remarkable downregulation of H3R17me levels and developmental defects in pre-implantation and fetal embryos. Transcriptomic analysis reveals that Yap1 and cell cycle signaling pathways are dysregulated in Carm1 truncation and H3R17H substitution embryos, and Yap1 overexpression could rescue the base-editing-elicited defects. Our data establish the direct regulatory relationship between CARM1-mediated H3R17me and early mouse embryo development and demonstrate that Yap1 acts downstream of CARM1-mediated H3R17me to regulate the mouse embryo development.Entities:
Keywords: CARM1; H3R17; Yap1 signaling; base editing; embryo development; histone methylation
Mesh:
Substances:
Year: 2019 PMID: 30625312 DOI: 10.1016/j.celrep.2018.12.046
Source DB: PubMed Journal: Cell Rep Impact factor: 9.423